Milestone Scientific (NYSE:MLSS) Stock Price Down 2.5% – What’s Next? - American Market News
Author: ABMN Staff
Description: Read Milestone Scientific (NYSE:MLSS) Stock Price Down 2.5% – What’s Next? at American Market News
Keywords: Milestone Scientific,NYSE:MLSS,MLSS,Medical,Stocks,Technicals
Date: 2026-06-13T01:59:30+0000

Skip to main content

# Milestone Scientific (NYSE:MLSS) Stock Price Down 2.5% – What’s Next?

Posted by ABMN Staff on Jun 13th, 2026

Share on Twitter
Share on Facebook
Share on LinkedIn
Share on Stocktwits

Milestone Scientific Inc. (NYSE:MLSS – Get Free Report)’s stock price was down 2.5% during trading on Friday . The stock traded as low as $0.35 and last traded at $0.35. Approximately 83,951 shares traded hands during mid-day trading, a decline of 93% from the average daily volume of 1,280,632 shares. The stock had previously closed at $0.3590.

Get Milestone Scientific alerts:

## Milestone Scientific Stock Performance

The firm has a market cap of $30.96 million, a P/E ratio of -5.00 and a beta of 1.04. The firm’s fifty day moving average price is $0.35 and its 200 day moving average price is $0.31.

## Institutional Inflows and Outflows

An institutional investor recently raised its position in Milestone Scientific stock. Raymond James Financial Inc. boosted its stake in shares of Milestone Scientific Inc. (NYSE:MLSS – Free Report) by 416.7% during the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 62,000 shares of the company’s stock after purchasing an additional 50,000 shares during the period. Raymond James Financial Inc. owned approximately 0.08% of Milestone Scientific worth $39,000 at the end of the most recent reporting period. Institutional investors own 5.79% of the company’s stock.

## Milestone Scientific Company Profile

(Get Free Report)

Milestone Scientific, Inc, listed on the New York Stock Exchange under the symbol MLSS, is a medical device company specializing in the development and commercialization of computer-controlled injection technologies for local anesthesia and pain management. The company’s proprietary systems are designed to enhance patient comfort, improve clinical outcomes and streamline the administration of anesthetics in dental and medical procedures. Through its precision delivery platforms, Milestone Scientific aims to set a new standard for minimally invasive injections.

At the core of Milestone Scientific’s product portfolio is the Single Tooth Anesthesia (STA) System, which uses Comunication Controlled Local Anesthetic Delivery (CCLAD) technology to provide targeted, atraumatic anesthesia for individual dental roots.

## Recommended Stories

- Five stocks we like better than Milestone Scientific
- SpaceX Rings the Bell and Shatters Every Record
- Adobe Stock Just Got Cheaper—Is Wall Street Missing the Story?
- 3 Dividend Stocks Under $50 That Pay You to Wait Out Inflation
- The 127-Gigawatt Problem: Why AI Needs Its Own Power

Receive News & Ratings for Milestone Scientific Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Milestone Scientific and related companies with MarketBeat.com's FREE daily email newsletter.

## You might be interested in:

Adobe Price Target Cut to $228.00 by Analysts at Citigroup
Clal Insurance Enterprises Holdings Ltd Increases Stake in iShares MSCI ACWI ex U.S. ETF $ACWX
Cohen & Steers Inc. Boosts Stock Position in Mplx Lp $MPLX
Cohen & Steers Inc. Takes $59.23 Million Position in DiamondRock Hospitality Company $DRH
Cohen & Steers Inc. Trims Stock Position in Prologis, Inc. $PLD
Clal Insurance Enterprises Holdings Ltd Invests $1.17 Million in TripAdvisor, Inc. $TRIP